2021 Pediatric Asthma Training

Asthma is the most common chronic condition among pediatric patients. About 5.5 million children under the age of 18 are currently diagnosed with asthma, and it’s the third leading cause of hospitalization among children under the age of 15. Uncontrolled asthma can result in chronic lingering symptoms, permanent lung damage, unnecessary emergency room visits, hospitalizations and even death.

The VHAN Pediatric Clinical Advisory Committee (PCAC) defines asthma performance as part of the pediatric modifier. VHAN members share the responsibility for quality and cost goals, and improving pediatric asthma performance is one of the contributing factors to reaching these goals.

On Thursday, May 6 from 12 to 1 p.m. CDT, join the VHAN pediatric team for a new annual training that counts toward your modifier. During the training, Leonard B. Bacharier, MD, will discuss:

  • Optimal intervention strategies for preschool children with both mild persistent asthma and severe episodic wheezing
  • Tactics for phenotype-directed therapy in preschool children
  • Strategies for treatment modification in the Yellow Zone

Meet Our Expert:

Dr. Bacharier is a professor in pediatrics at Vanderbilt University Medical School and section chief of pediatric allergy and immunology. He is also the scientific director of the Center for Clinical and Translational Research and the Director of the Center for Pediatric Asthma Research at Vanderbilt University Medical Center.

Webinar Details:

Thursday, May 6, 12 – 1 p.m. CDT

Attendees will have the opportunity to participate in a live Q&A with Dr. Bacharier at the end of the webinar.

We look forward to having you join the conversation!

For additional information, connect with us at [email protected].